Drug Type Small molecule drug |
Synonyms DDC1, PARP AR, DDC 1 |
Target |
Action stimulants |
Mechanism MEK1 stimulants(Dual specificity mitogen-activated protein kinase kinase 1 stimulants) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H15Cl2NO5 |
InChIKeyKKWCKLTVJHTSHF-UHFFFAOYSA-N |
CAS Registry64411-63-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Cancer | Preclinical | United States | - |





